Whit Mayo
Stock Analyst at Leerink Partners
(2.52)
# 2,275
Out of 5,124 analysts
152
Total ratings
52.58%
Success rate
10.62%
Average return
Main Sectors:
Stocks Rated by Whit Mayo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Downgrades: Market Perform | $25 → $14 | $14.19 | -1.34% | 11 | Dec 3, 2025 | |
| MD Pediatrix Medical Group | Maintains: Market Perform | $15 → $17 | $21.39 | -20.52% | 11 | Sep 5, 2025 | |
| ELV Elevance Health | Downgrades: Market Perform | $510 → $310 | $350.55 | -11.57% | 4 | Jul 18, 2025 | |
| AIRS AirSculpt Technologies | Maintains: Market Perform | $6.5 → $2.5 | $1.98 | +26.26% | 5 | Mar 31, 2025 | |
| AHCO AdaptHealth | Maintains: Buy | $12 → $11 | $9.96 | +10.44% | 11 | Feb 13, 2025 | |
| EHAB Enhabit | Reiterates: Market Perform | $8.5 → $8 | $9.22 | -13.23% | 2 | Nov 19, 2024 | |
| ARDT Ardent Health | Maintains: Outperform | $23 → $25 | $8.83 | +183.13% | 2 | Nov 12, 2024 | |
| HUM Humana | Downgrades: Market Perform | $400 → $250 | $256.13 | -2.39% | 12 | Oct 2, 2024 | |
| EHC Encompass Health | Initiates: Outperform | $100 | $106.14 | -5.78% | 1 | Jul 10, 2024 | |
| BTSG BrightSpring Health Services | Initiates: Outperform | $15 | $37.45 | -59.95% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $560 | $330.11 | +69.64% | 11 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $218.02 | - | 11 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $129.01 | -24.81% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $275.23 | +21.72% | 5 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $466.86 | -38.74% | 17 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $15.45 | +158.90% | 7 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $23.71 | +64.49% | 7 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $1.5 | $2.35 | -36.17% | 4 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $30 | $0.69 | +4,256.03% | 5 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $55 | $198.72 | -72.32% | 14 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $86.47 | +102.38% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $19.75 | -3.80% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $3.12 | +28.21% | 6 | Jul 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $250.88 | -19.08% | 2 | May 1, 2018 |
Acadia Healthcare Company
Dec 3, 2025
Downgrades: Market Perform
Price Target: $25 → $14
Current: $14.19
Upside: -1.34%
Pediatrix Medical Group
Sep 5, 2025
Maintains: Market Perform
Price Target: $15 → $17
Current: $21.39
Upside: -20.52%
Elevance Health
Jul 18, 2025
Downgrades: Market Perform
Price Target: $510 → $310
Current: $350.55
Upside: -11.57%
AirSculpt Technologies
Mar 31, 2025
Maintains: Market Perform
Price Target: $6.5 → $2.5
Current: $1.98
Upside: +26.26%
AdaptHealth
Feb 13, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $9.96
Upside: +10.44%
Enhabit
Nov 19, 2024
Reiterates: Market Perform
Price Target: $8.5 → $8
Current: $9.22
Upside: -13.23%
Ardent Health
Nov 12, 2024
Maintains: Outperform
Price Target: $23 → $25
Current: $8.83
Upside: +183.13%
Humana
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $256.13
Upside: -2.39%
Encompass Health
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $106.14
Upside: -5.78%
BrightSpring Health Services
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $37.45
Upside: -59.95%
Jun 14, 2023
Maintains: Outperform
Price Target: $625 → $560
Current: $330.11
Upside: +69.64%
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $218.02
Upside: -
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $129.01
Upside: -24.81%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $275.23
Upside: +21.72%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $466.86
Upside: -38.74%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $15.45
Upside: +158.90%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $23.71
Upside: +64.49%
Nov 8, 2022
Maintains: Market Perform
Price Target: $3 → $1.5
Current: $2.35
Upside: -36.17%
Nov 4, 2022
Maintains: Outperform
Price Target: $33 → $30
Current: $0.69
Upside: +4,256.03%
Oct 25, 2022
Maintains: Outperform
Price Target: $89 → $55
Current: $198.72
Upside: -72.32%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $86.47
Upside: +102.38%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $19.75
Upside: -3.80%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $3.12
Upside: +28.21%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $250.88
Upside: -19.08%